Sivik Global Healthcare’s Chemed CHE Stock Holding History

Sivik Global Healthcare’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,500	Closed	-$2.05M	–	66
2018 Q1	$2.05M	Sell	7,500 -2,500	-25%	-$662K	0.95%	44
2017 Q4	$2.43M	Sell	10,000 -2,500	-20%	-$568K	0.9%	51
2017 Q3	$2.53M	Hold	12,500	–	–	0.86%	42
2017 Q2	$2.56M	Sell	12,500 -2,500	-17%	-$498K	0.94%	46
2017 Q1	$2.74M	Hold	15,000	–	–	1.28%	33
2016 Q4	$2.41M	Hold	15,000	–	–	1.15%	34
2016 Q3	$2.12M	Sell	15,000 -10,000	-40%	-$1.39M	1.07%	36
2016 Q2	$3.41M	Sell	25,000 -15,000	-38%	-$1.99M	1.69%	30
2016 Q1	$5.42M	Buy	40,000 +15,000	+60%	+$2.03M	2.4%	14
2015 Q4	$3.75M	Buy	25,000 +9,004	+56%	+$1.33M	1.78%	24
2015 Q3	$2.13M	Buy	+15,996	New	+$2.24M	1.04%	39

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Sivik Global Healthcare's CHE Position: Q2 2018 in Review

Sivik Global Healthcare sold out of Chemed (CHE) in Q2 2018, closing a stake of 7,500 shares — an estimated $2.05M sold.

Sivik Global Healthcare first reported a position in CHE in Q3 2015 and held it in 11 quarters. The position peaked at $5.42M in Q1 2016. 330 funds tracked by Wall St. Rank hold CHE as of Q2 2018.

Sivik Global Healthcare reported no remaining Chemed position as of Q2 2018 after selling out during the quarter.
Sivik Global Healthcare sold 7,500 Chemed shares in Q2 2018, an estimated $2.05M.
Sivik Global Healthcare first reported a position in Chemed in Q3 2015 and held it in 11 quarters.
Sivik Global Healthcare's Chemed position peaked at $5.42M in Q1 2016.
330 funds tracked by Wall St. Rank held Chemed as of Q2 2018.

Based on Sivik Global Healthcare's 13F filing for Q2 2018, filed 6 Aug 2018.